Catawba Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Catawba Capital Management's LLY Position: Q2 2018 in Review
Catawba Capital Management increased its Eli Lilly (LLY) stake by 18% in Q2 2018, buying an estimated $184K and bringing the position to 14,883 shares worth $1.27M. The position accounts for 0.3% of the portfolio, ranked #78.
Catawba Capital Management first reported a position in LLY in Q2 2013 and has held it in 21 quarters since. 1,368 funds tracked by Wall St. Rank hold LLY as of Q2 2018.
- Catawba Capital Management held 14,883 shares of Eli Lilly worth $1.27M as of Q2 2018.
- Catawba Capital Management bought 2,240 Eli Lilly shares in Q2 2018, an estimated $184K.
- Eli Lilly made up 0.3% of Catawba Capital Management's portfolio in Q2 2018, its #78 holding.
- Catawba Capital Management first reported a position in Eli Lilly in Q2 2013 and has held it in 21 quarters since.
- 1,368 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2018.
Based on Catawba Capital Management's 13F filing for Q2 2018, filed 11 Jul 2018.